|
ZBTB38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.441700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.580600E-04 |
| Normal-vs-Stage2 |
5.701000E-01 |
| Normal-vs-Stage3 |
4.847000E-01 |
| Normal-vs-Stage4 |
9.617000E-01 |
| Stage1-vs-Stage2 |
2.354600E-01 |
| Stage1-vs-Stage3 |
1.232560E-01 |
| Stage1-vs-Stage4 |
4.749200E-01 |
| Stage2-vs-Stage3 |
3.689600E-01 |
| Stage2-vs-Stage4 |
8.026000E-01 |
| Stage3-vs-Stage4 |
7.196400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.490500E-02 |
| Normal-vs-AfricanAmerican |
1.248980E-01 |
| Normal-vs-Asian |
1.283430E-01 |
| Caucasian-vs-AfricanAmerican |
8.580200E-01 |
| Caucasian-vs-Asian |
9.265000E-01 |
| AfricanAmerican-vs-Asian |
8.579600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56341999999476E-05 |
| Normal-vs-Female |
1.196980E-01 |
| Male-vs-Female |
4.399800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.084800E-01 |
| Normal-vs-Extreme_Weight |
8.98679999972174E-07 |
| Normal-vs-Obese |
8.703400E-01 |
| Normal-vs-Extreme_Obese |
3.207800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.946300E-02 |
| Normal_Weight-vs-Obese |
6.354000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.726800E-01 |
| Extreme_Weight-vs-Obese |
1.993750E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.090200E-01 |
| Obese-vs-Extreme_Obese |
6.065400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.162200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.442960E-01 |
| Normal-vs-Age(61-80Yrs) |
1.341180E-03 |
| Normal-vs-Age(81-100Yrs) |
7.95260000000519E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.196400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.439570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.824200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.495980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.380000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.203230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.53969999999926E-05 |
| Normal-VS-Type2 PRCC |
1.446500E-02 |
| Normal-VS-KIRP CIMP |
5.464000E-02 |
| Normal-VS-Unclassified PRCC |
8.315000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.535200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.915900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.811700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.375500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.578950E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.399800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.386710E-04 |
| Normal-vs-N1 |
4.383600E-01 |
| Normal-vs-N2 |
6.615800E-01 |
| N0-vs-N1 |
8.572000E-02 |
| N0-vs-N2 |
4.811000E-01 |
| N1-vs-N2 |
7.830800E-01 |
|
|
